Drug intelligence / Profile preview

Sukshma Vara

Development stage: Unknown
Lead developer: Chaitanya Pharmaceuticals
Administration: Oral

Overview

Sukshma Vara is an Ayurvedic proprietary medicine manufactured by Chaitanya Pharmaceuticals. It is formulated as a 300 mg tablet containing a blend of traditional herbs, including Triphala (Haritaki, Behada, and Amalaki), Bhuiamalki, Anantmool, Guduchi, and Neem (Kadunimbapatra), along with purified mercury (Shuddha Parad) and purified sulfur (Shuddha Gandhak). Sukshma Vara acts as an immunomodulator, antibacterial, and antiviral agent. It is primarily indicated for the prevention and treatment of upper respiratory tract infections, urinary tract infections, allergic disorders, coughs, colds, dental and periodontal infections, stomatitis, styes, and conjunctivitis.

Brand names: Sukshma Vara
Other names: Sukshma Vara TriphalaSukshma Vara Triphala Ghana

Beyond the preview

Go deeper on Sukshma Vara.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sukshma Vara.

Explore the full profile